Skip to main content
. Author manuscript; available in PMC: 2024 Jan 15.
Published in final edited form as: Lung Cancer. 2023 Oct 4;185:107387. doi: 10.1016/j.lungcan.2023.107387

Table 2.

Twelve-year mortality and incidence data stratified by sex.

TOTAL 6495 FEMALES 2368 (36.5 %) MALES 4127 (63.5 %) Chi-square p-value

12-year outcomes
All-cause deaths*
417 (6.4 %) 98 (4.1 %) 319 (7.7 %) <0.001
Lung cancer deaths 103 (1.6 %) 24 (1.0 %) 79 (1.9 %) 0.0052
Other cancer deaths 120 (1.9 %) 32 (1.4 %) 88 (2.15 %) 0.0245
CVD deaths 73 (1.1 %) 17 (0.7 %) 56 (1.4 %) 0.0187
Other causes of deaths 76 (1.2 %) 15 (0.6 %) 61 (1.5 %) 0.0023
Non-cancer deaths 149 (2.3
%)
32 (1.4 %) 117 (2.8 %) 0.001
Non-CVD deaths 299 (4.6
%)
71 (3.0 %) 228 (5.5 %) <0.001
Lung cancer incidence 299 (4.6
%)
105 (4.4 %) 194 (4.7 %) 0.62
Proportion of stage I 161 (53.9 %) 61 (58.1 %) 100 (51.2 %) 0.27
*

Missing causes of deaths N = 45.